Related Experiment Video

Updated: Jun 19, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic

Christine A Larsen1, William H Bisson, Roderick H Dashwood

  • 1Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331, USA.

Journal of Medicinal Chemistry
|October 21, 2009
PubMed

Insights

Tea compounds called catechins may stop cancer spread by inhibiting the MET protein. Researchers found catechins can suppress MET activation in colon cancer cells, potentially blocking metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer metastasis, the spread of tumors to distant sites, is the primary cause of cancer-related mortality.
  • The MET protein plays a crucial role in facilitating metastasis across various cancer types.
  • Understanding the molecular mechanisms driving metastasis is essential for developing targeted therapies.

Purpose of the Study:

  • To investigate the potential of tea catechins in suppressing MET protein activation.
  • To elucidate the mechanism by which tea catechins might inhibit MET activity in cancer cells.
  • To explore a novel therapeutic strategy for combating cancer metastasis.

Main Methods:

  • Utilizing human colon cancer cell lines.
  • Assessing the impact of tea catechins on MET protein activation.
  • Proposing a mechanism involving competition for the MET kinase domain.

Main Results:

  • Tea catechins demonstrated the ability to suppress MET activation in human colon cancer cells.
  • A potential mechanism suggests catechins compete with substrates for the MET kinase domain.
  • This inhibition could impede the signaling pathways crucial for metastasis.

Conclusions:

  • Tea catechins show promise as inhibitors of MET signaling.
  • This finding suggests a potential natural compound-based approach to target cancer metastasis.
  • Further research into catechins could lead to new anti-metastatic therapies.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...